SMART pass will prevent inappropriate operation of S-ICD

Motomi Tachibana, Nobuhiro Nishii, Kimikazu Banba, Shinpei Fujita, Etsuko Ikeda, Keisuke Okawa, Hiroshi Morita, Hiroshi Itoh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Compared to screening ECG before implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), selectable vectors without T-wave oversensing increase after S-ICD implantation. Newer algorithms have recently become available to reduce T-wave oversensing, such as SMART pass (SP). With this function, more selectable vectors are identified after S-ICD implantation. However, this improvement in eligibility utilizing SP has not yet been well validated. We aimed to clarify S-ICD eligibility before and after S-ICD implantation with and without SP. Methods: Participants comprised 34 patients implanted with an S-ICD at Okayama University Hospital and its affiliated hospitals between February 2016 and August 2017. A total of 102 S-ICD vectors were assessed for eligibility before and after S-ICD implantation, at rest and during exercise testing. Vector availability was evaluated in the presence and absence of SP after S-ICD implantation. Results: Subcutaneous implantable cardioverter-defibrillator eligibility was significantly better after implantation even without SP than S-ICD screening before S-ICD implantation, both at rest (before 65.7% vs after 95.1%, P < 0.01) and during exercise (before 59.3% vs after 90.6%, P < 0.01). SP improved S-ICD eligibility during exercise (SP on 97.9% vs off 90.6%, P = 0.03). Multivariate analysis showed the prevalence of S-ICD eligibility increased significantly after S-ICD implantation compared to screening before implantation. SP further increased selectable vectors in multivariate analysis. Conclusion: Available vectors increased significantly after S-ICD implantation compared to preoperative vectors as assessed by S-ICD screening ECG. T-wave oversensing during exercise has been an unresolved issue for S-ICD, but SP will help prevent inappropriate operation with S-ICD.

Original languageEnglish
JournalJournal of Arrhythmia
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Implantable Defibrillators
Exercise
Electrocardiography
Multivariate Analysis

Keywords

  • implantable cardioverter-defibrillator
  • inappropriate shock
  • SMART Pass
  • subcutaneous implantable cardioverter-defibrillator
  • T-wave oversensing

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

SMART pass will prevent inappropriate operation of S-ICD. / Tachibana, Motomi; Nishii, Nobuhiro; Banba, Kimikazu; Fujita, Shinpei; Ikeda, Etsuko; Okawa, Keisuke; Morita, Hiroshi; Itoh, Hiroshi.

In: Journal of Arrhythmia, 01.01.2018.

Research output: Contribution to journalArticle

Tachibana, Motomi ; Nishii, Nobuhiro ; Banba, Kimikazu ; Fujita, Shinpei ; Ikeda, Etsuko ; Okawa, Keisuke ; Morita, Hiroshi ; Itoh, Hiroshi. / SMART pass will prevent inappropriate operation of S-ICD. In: Journal of Arrhythmia. 2018.
@article{f3c2fd4a64174d99927580285ff2c4fd,
title = "SMART pass will prevent inappropriate operation of S-ICD",
abstract = "Background: Compared to screening ECG before implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), selectable vectors without T-wave oversensing increase after S-ICD implantation. Newer algorithms have recently become available to reduce T-wave oversensing, such as SMART pass (SP). With this function, more selectable vectors are identified after S-ICD implantation. However, this improvement in eligibility utilizing SP has not yet been well validated. We aimed to clarify S-ICD eligibility before and after S-ICD implantation with and without SP. Methods: Participants comprised 34 patients implanted with an S-ICD at Okayama University Hospital and its affiliated hospitals between February 2016 and August 2017. A total of 102 S-ICD vectors were assessed for eligibility before and after S-ICD implantation, at rest and during exercise testing. Vector availability was evaluated in the presence and absence of SP after S-ICD implantation. Results: Subcutaneous implantable cardioverter-defibrillator eligibility was significantly better after implantation even without SP than S-ICD screening before S-ICD implantation, both at rest (before 65.7{\%} vs after 95.1{\%}, P < 0.01) and during exercise (before 59.3{\%} vs after 90.6{\%}, P < 0.01). SP improved S-ICD eligibility during exercise (SP on 97.9{\%} vs off 90.6{\%}, P = 0.03). Multivariate analysis showed the prevalence of S-ICD eligibility increased significantly after S-ICD implantation compared to screening before implantation. SP further increased selectable vectors in multivariate analysis. Conclusion: Available vectors increased significantly after S-ICD implantation compared to preoperative vectors as assessed by S-ICD screening ECG. T-wave oversensing during exercise has been an unresolved issue for S-ICD, but SP will help prevent inappropriate operation with S-ICD.",
keywords = "implantable cardioverter-defibrillator, inappropriate shock, SMART Pass, subcutaneous implantable cardioverter-defibrillator, T-wave oversensing",
author = "Motomi Tachibana and Nobuhiro Nishii and Kimikazu Banba and Shinpei Fujita and Etsuko Ikeda and Keisuke Okawa and Hiroshi Morita and Hiroshi Itoh",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/joa3.12141",
language = "English",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - SMART pass will prevent inappropriate operation of S-ICD

AU - Tachibana, Motomi

AU - Nishii, Nobuhiro

AU - Banba, Kimikazu

AU - Fujita, Shinpei

AU - Ikeda, Etsuko

AU - Okawa, Keisuke

AU - Morita, Hiroshi

AU - Itoh, Hiroshi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Compared to screening ECG before implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), selectable vectors without T-wave oversensing increase after S-ICD implantation. Newer algorithms have recently become available to reduce T-wave oversensing, such as SMART pass (SP). With this function, more selectable vectors are identified after S-ICD implantation. However, this improvement in eligibility utilizing SP has not yet been well validated. We aimed to clarify S-ICD eligibility before and after S-ICD implantation with and without SP. Methods: Participants comprised 34 patients implanted with an S-ICD at Okayama University Hospital and its affiliated hospitals between February 2016 and August 2017. A total of 102 S-ICD vectors were assessed for eligibility before and after S-ICD implantation, at rest and during exercise testing. Vector availability was evaluated in the presence and absence of SP after S-ICD implantation. Results: Subcutaneous implantable cardioverter-defibrillator eligibility was significantly better after implantation even without SP than S-ICD screening before S-ICD implantation, both at rest (before 65.7% vs after 95.1%, P < 0.01) and during exercise (before 59.3% vs after 90.6%, P < 0.01). SP improved S-ICD eligibility during exercise (SP on 97.9% vs off 90.6%, P = 0.03). Multivariate analysis showed the prevalence of S-ICD eligibility increased significantly after S-ICD implantation compared to screening before implantation. SP further increased selectable vectors in multivariate analysis. Conclusion: Available vectors increased significantly after S-ICD implantation compared to preoperative vectors as assessed by S-ICD screening ECG. T-wave oversensing during exercise has been an unresolved issue for S-ICD, but SP will help prevent inappropriate operation with S-ICD.

AB - Background: Compared to screening ECG before implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD), selectable vectors without T-wave oversensing increase after S-ICD implantation. Newer algorithms have recently become available to reduce T-wave oversensing, such as SMART pass (SP). With this function, more selectable vectors are identified after S-ICD implantation. However, this improvement in eligibility utilizing SP has not yet been well validated. We aimed to clarify S-ICD eligibility before and after S-ICD implantation with and without SP. Methods: Participants comprised 34 patients implanted with an S-ICD at Okayama University Hospital and its affiliated hospitals between February 2016 and August 2017. A total of 102 S-ICD vectors were assessed for eligibility before and after S-ICD implantation, at rest and during exercise testing. Vector availability was evaluated in the presence and absence of SP after S-ICD implantation. Results: Subcutaneous implantable cardioverter-defibrillator eligibility was significantly better after implantation even without SP than S-ICD screening before S-ICD implantation, both at rest (before 65.7% vs after 95.1%, P < 0.01) and during exercise (before 59.3% vs after 90.6%, P < 0.01). SP improved S-ICD eligibility during exercise (SP on 97.9% vs off 90.6%, P = 0.03). Multivariate analysis showed the prevalence of S-ICD eligibility increased significantly after S-ICD implantation compared to screening before implantation. SP further increased selectable vectors in multivariate analysis. Conclusion: Available vectors increased significantly after S-ICD implantation compared to preoperative vectors as assessed by S-ICD screening ECG. T-wave oversensing during exercise has been an unresolved issue for S-ICD, but SP will help prevent inappropriate operation with S-ICD.

KW - implantable cardioverter-defibrillator

KW - inappropriate shock

KW - SMART Pass

KW - subcutaneous implantable cardioverter-defibrillator

KW - T-wave oversensing

UR - http://www.scopus.com/inward/record.url?scp=85056798125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056798125&partnerID=8YFLogxK

U2 - 10.1002/joa3.12141

DO - 10.1002/joa3.12141

M3 - Article

AN - SCOPUS:85056798125

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

ER -